Your browser doesn't support javascript.
loading
Clinical prognostic value of the SMYD2/3 as new epigenetic biomarkers in solid cancer patients: a systematic review and meta-analysis.
Razmi, Mahdieh; Yazdanpanah, Ayna; Etemad-Moghadam, Shahroo; Alaeddini, Mojgan; Angelini, Sabrina; Eini, Leila.
Afiliação
  • Razmi M; Dental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Yazdanpanah A; Oncopathology Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran.
  • Etemad-Moghadam S; Department of Tissue Engineering and Regenerative Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • Alaeddini M; Dental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Angelini S; Dental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Eini L; Department of Pharmacy and Biotechnology (Fabit), University of Bologna, Bologna, Italy.
Expert Rev Mol Diagn ; : 1-15, 2022 Nov 17.
Article em En | MEDLINE | ID: mdl-36346387
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Systematic_reviews Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Systematic_reviews Idioma: En Ano de publicação: 2022 Tipo de documento: Article